Keytruda

green light go go ahead advance yes streetlight
Biotech

Moderna posts melanoma data behind decision to say 'I do' to IDO

Responses in melanoma patients failed by checkpoint inhibitors informed a decision to expand and prioritize development of the cancer candidate.
Nick Paul Taylor Oct 13, 2025 5:15am
next step ladder climb succeed win

PDS reports 39 months OS in phase 2 head and neck cancer trial

Aug 25, 2025 9:00am
Tecentriq
Favicon Fierce Pharma

Roche touts Tecentriq biomarker win in bladder cancer

Aug 18, 2025 4:17pm
dart board miss failure

Cancer vaccine's 'narrow' fail won't stop IO heading to FDA

Aug 11, 2025 9:48am
Merck Co
Favicon Fierce Pharma

Merck unveils $3B cost-cutting plan

Jul 29, 2025 8:15am
Businessman climbing steps to pluck a star from the sky

Merus hails 'unprecedented' survival on solid tumor bispecific

May 23, 2025 7:35am